---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-016272"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2022-12-08T23:59:59+00:00"
generated_at: "2026-06-21T07:34:54.634316+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ENDRA Life Sciences to effect 1-for-20 reverse stock split on Dec 9, 2022

## Summary
- Stockholders approved the 1-for-20 reverse split at a special meeting on November 29, 2022.
- Effective 12:01 a.m. ET Dec 9; every 20 outstanding shares become 1 share; fractional shares rounded up.
- Authorized shares remain 80M; exercise price and share counts for outstanding options proportionally adjusted.
- Common stock will trade on Nasdaq on a split-adjusted basis under symbol NDRA; new CUSIP 29273B302.

## SEC filing metadata
- accession: 0001654954-22-016272
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2022-12-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000165495422016272/0001654954-22-016272-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000165495422016272/endra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-016272
- JSON: https://secwatch.observer/filing/0001654954-22-016272.json
- Plain text: https://secwatch.observer/filing/0001654954-22-016272.txt

## Key facts
- Governance Changes
  ENDRA Life Sciences Inc.: Effected a 1-for-20 reverse stock split of common stock through a Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation (effective 2022-12-09).
  - Change: charter amendment
  - Effective: 2022-12-09
  source text: On December 8, 2022, ENDRA Life Sciences Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Fourth Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) with the Secretary of State of Delaware to effect a 1-for-20 reverse stock split of the shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), either issued and outstanding or held by the Company as treasury stock, effective as of 12:01 a.m. (Eastern time) on December 9, 2022 (the “Reverse Stock Split”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1681682/000165495422016272/0001654954-22-016272-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.